Syndecan 4 Mediates Nrf2-dependent Expansion of Bronchiolar Progenitors That Protect Against Lung Inflammation
Arif Santoso1, Toshiaki Kikuchi1,2, Naoki Tode3
1Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
Abstract:
The use of lung progenitors for regenerative medicine appears promising, but their biology is not fully understood. Here, we found anti-inflammatory attributes in bronchiolar progenitors that were sorted as a multipotent subset of mouse club cells and found to express secretory leukocyte protease inhibitor (SLPI). Notably, the impaired expression of SLPI in mice increased the number of bronchiolar progenitors and decreased the lung inflammation. We determined a transcriptional profile for the bronchiolar progenitors of Slpi-deficient mice and identified syndecan 4, whose expression was markedly elevated as compared to that of wild-type mice. Systemic administration of recombinant syndecan 4 protein caused a substantial increase in the number of bronchiolar progenitors with concomitant attenuation of both airway and alveolar inflammation. The syndecan 4 administration also resulted in activation of the Keap1-Nrf2 antioxidant pathway in lung cells, which is critically involved in the therapeutic responses to the syndecan 4 treatment. Moreover, in 3D culture, the presence of syndecan 4 induced differentiated club cells to undergo Nrf2-dependent transition into bronchiolar progenitors. Our observations reveal that differentiative switches between bronchiolar progenitors and club cells are under the Nrf2-mediated control of SLPI and syndecan 4, suggesting the possibility of new therapeutic approaches in inflammatory lung diseases.
Insights
Secretory leukocyte protease inhibitor (SLPI) and syndecan 4 regulate lung progenitor cells. Targeting these molecules may offer new therapies for inflammatory lung diseases.
Area of Science:
- Pulmonary Medicine
- Regenerative Medicine
- Cell Biology
Background:
- Lung progenitor cells are crucial for regenerative medicine, but their biology remains incompletely understood.
- Bronchiolar progenitors, a subset of mouse club cells, exhibit anti-inflammatory properties linked to secretory leukocyte protease inhibitor (SLPI).
- Dysregulated SLPI expression impacts progenitor numbers and lung inflammation.
Purpose of the Study:
- To investigate the role of SLPI and identify novel factors regulating bronchiolar progenitors.
- To explore the therapeutic potential of identified factors in inflammatory lung conditions.
Main Methods:
- Cell sorting and characterization of mouse bronchiolar progenitors.
- Transcriptional profiling of Slpi-deficient bronchiolar progenitors.
- Systemic administration of recombinant syndecan 4 protein in mice.
- Analysis of the Keap1-Nrf2 antioxidant pathway.
- 3D cell culture models to study cell differentiation.
Main Results:
- Impaired SLPI expression in mice led to increased bronchiolar progenitors and reduced lung inflammation.
- Syndecan 4 was identified as upregulated in Slpi-deficient progenitors.
- Recombinant syndecan 4 administration increased progenitor numbers and attenuated airway and alveolar inflammation.
- Syndecan 4 activated the Keap1-Nrf2 antioxidant pathway, crucial for therapeutic effects.
- Syndecan 4 induced Nrf2-dependent club cell transition to bronchiolar progenitors in 3D culture.
Conclusions:
- Differentiative switching between bronchiolar progenitors and club cells is controlled by the Nrf2 pathway, modulated by SLPI and syndecan 4.
- These findings suggest novel therapeutic strategies for inflammatory lung diseases by targeting the SLPI-syndecan 4-Nrf2 axis.
Related Concept Videos
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Gross Anatomy of the Lungs
TGF - β Signaling Pathway
The Bronchial Tree
The trachea, commonly known as the windpipe, is a tube that connects the larynx (voice box) to the bronchi. At a point called the carina, it bifurcates into two primary bronchi. The right primary bronchus is wider, shorter, and more vertical than the left primary...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation


